You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華仁藥業:子公司華仁醫療擬投建醫用口罩生產線
格隆匯 02-11 20:26

格隆匯2月11日丨華仁藥業(300110.SZ)公佈,面對當前“新型冠狀病毒肺炎疫情”防控進入關鍵期,醫療防護物資嚴重短缺的局面,為積極響應國家和地方政府的號召,以實際行動支持新型冠狀病毒的防疫工作,踐行上市公司社會責任,公司全資子公司青島華仁醫療用品有限公司(“華仁醫療”)擬充分發揮自身優勢,在目前的淨化廠房中改建醫用口罩生產線,用於生產醫用防護口罩生產線(N95)、一次性使用醫用口罩等醫療防護用品。

此次項目建設內容:2條醫用防護口罩生產線(N95);1條一次性使用醫用口罩生產線。建設規模:年產一次性使用醫用口罩4600萬隻、醫用防護口罩(N95)2500萬隻。

受“新型冠狀病毒肺炎”疫情影響,目前口罩等醫療防護用品的市場需求急劇增長,全國各地市場供應短缺,在黨和國家的號召以及政府相關政策的支持與幫助下,為有效緩解全國疫情防護物資供應不足的問題,公司擬投資生產符合相關質量標準的一次性使用醫用口罩、醫用防護口罩等醫療防護用品,全力支持疫情防控工作,同時滿足市場需求。

公司目前主營業務為基礎性輸液、治療性輸液、腹膜透析液、醫療器械及藥包材等,是山東省應急儲備定點輸液生產企業,深耕輸液領域二十餘年,憑藉國際先進的輸液製造設備和技術,全面全過程的生產質量控制,完善的質量管理和優良的品質,公司產品被客户廣泛接受和認可,積累了豐富的客户資源。項目的建設可充分發揮公司自身優勢,充分利用現有資源,在現有廠房基礎上進行口罩生產線建設,項目投資孝建設週期短,短期內即可實現規模化生產,項目達產後,將進一步豐富公司產品線,有利於疫情防控物資的補給及滿足後續市場對於醫用口罩的需求,具有很強的戰略佈局和現實的社會意義。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account